Additionally, immunofluorescence further demonstrated that SCH significantly reduced the percentage of Ki67-positive cells to 61.31% in MSC-Exo-treated EC (Fig. 4e, f). This evidence concerns the gene MKI67 and spindle cell hemangioma.